Portugal
Scientific society wants to “democratize” cardiovascular screenings through pharmacies
Publication: PÚBLICO
Author: publico@publico.pt
Source published: 27/09/2026, 10:12:58 UTC
Briefing created: 27/09/2026, 10:21:56 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 27/09/2026, 10:20:24 UTC.
Briefings
A Portuguese scientific society proposes a strategy to democratize cardiovascular risk screening by integrating it into pharmacy networks. This initiative aims to address the high mortality rate from heart disease and stroke, which currently claim the lives of one person every 15 minutes in Portugal. The project seeks to leverage existing pharmacy infrastructure to provide accessible health monitoring services to the general population.
Key points
- Cardiovascular diseases, including heart attacks and strokes, remain the leading cause of death in Portugal, killing one individual every 15 minutes.
- The initiative aims to integrate cardiovascular risk screening into pharmacy networks to democratize access to health monitoring services.
Context and limitations
The evidence provided is limited to a single sentence stating that cardiovascular diseases are the primary cause of death in Portugal and that they kill one person every 15 minutes. No specific details about the screening methodology, pharmacy network structure, implementation timeline, or expected outcomes are available in the source material.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 27/09/2026, 10:21:56 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeihz47ziv7axcxk2t6wwpft7asqnlifwpkpcg3ilchfp6jr44f2wuy